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To probe the location of the carboxyl-terminus of the 28 kDa apoprotein of the light-harvesting chlorophyll 
a/b-protein complex of PS II (LHCII), an antibody was generated against a synthetic octapeptide cor- 
responding to the C-terminal region of LHCII. The high specificity of the octapeptide antiserum was dem- 
onstrated by immunoblots and immunogold labelling. The octapeptide antiserum agglutinated destacked 
thylakoid membranes, but no significant agglutination occurred with inside-out vesicles suggesting that the 
COOH-terminus is located at the outer, stroma-exposed surface where the NH,-terminus is also located 
[(1983) J. Biol. Chem. 258, 9941-99481. Our results support a model for LHCII with four transmembrane- 
spanning domains. 
Chlorophyll a/b-protein; Carboxyl-terminal localization; Immunogold labeling; Light-harvesting complex; 
Photosynthesis; Thylakoid membrane 
1. INTRODUCTION 
The light-harvesting chlorophyll a/b-protein 
complex of PS II (LHCII) is the main protein com- 
plex of higher plant and green algal thylakoids. 
LHCII occurs mainly in the appressed grana mem- 
branes where it transfers light excitation energy to 
the PS II reaction center and mediates thylakoid 
stacking [l-3]. The chlorophyll a, chlorophyll b 
and xanthophylls of LHCII are noncovalently 
associated with several heterogeneous apoproteins 
of 24-30 kDa, but most plant species have two 
major apoproteins (28 and 26 kDa) of similar 
primary structure [2]. Both the 28 and 26 kDa pro- 
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teins of LHCII span the membrane [4,5] and their 
NHz-terminal regions are located at the outer 
membrane surface [6]. The LHCII apoproteins are 
encoded by a nuclear multigene family [7- 1 l] and 
the 28 kDa apoprotein gene has been cloned and 
sequenced [7,11- 141. The three-dimensional struc- 
ture of LHCII has been determined by image 
reconstruction from electron micrographs [ 15,161. 
A model with three transmembrane domains has 
been proposed for a Lemna Chl a/b-protein from 
hydropathy plot analysis [12]. To test this model 
experimentally, we have used antiserum generated 
against a synthetic octapeptide corresponding to 
the C-terminus of LHCII. Our agglutination 
studies suggest that he carboxyl-terminus is 
located at the outer surface and we propose a 
model for LHCII with four membrane-spanning 
domains. 
2. MATERIALS AND METHODS 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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Spinach thylakoid membranes [4] were de- 
stacked by incubation in 10 mM Tricine buffer 
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isolated by aqueous polymer two-phase partition 
[41. 
For use as an immunogen, the synthetic octa- 
peptide, NHz-Ala-Thr-Asn-Phe-Val-Pro-Gly-Lys- 
COOH (Dr J. Young, Children’s Hospital, 
Boston, MA), was coupled (in 20 mM excess) to 
BSA with glutaraldehyde [18]. The free peptide 
was removed by dialysis. The octapeptide-BSA 
conjugate (1 mg/ml) in 0.1 M phosphate buffer 
(pH 7.5) was emulsified with Freund’s complete 
adjuvant (day 0) or incomplete adjuvant (days 28, 
56) and injected into rabbits at multiple sites in- 
tradermally. Blood was taken 1 week after each 
booster injection, and the serum frozen at - 20°C. 
Polyvalent antisera against he 28 and 26 kDa pro- 
teins were raised in rabbits as in [4]. Proteins were 
electrophoretically transferred from SDS-PAGE 
slab gels [4] to nitrocellulose sheets [5], probed 
with octapeptide antibodies, and the antibody 
binding was detected with 5-bromo-4-chlor-3-indo- 
lyl phosphate and nitroblue tetrazolium (Promega 
Biotec., Madison). Immunogold labelling was car- 
ried out as in [19,20]. 
Fig.1. Specificity of the octapeptide antiserum. SDS- 
PAGE of standard markers (lane 1) and LHCII (lane 2). 
Western immunoblots of thylakoids (lanes 3,5) and 
LHCII (lanes 4,6) with polyvalent LHCII antisera (lanes 
3,4) and octapeptide antiserum (lanes 5,6). 
(pH 8.0), 100 mM sucrose for 1.5 h at 4°C [4]. 
LHCII was isolated by Triton X-100 solubilization 
of thylakoids [ 171. Right-side-out and inside-out 
thylakoid vesicles of uniform composition were 
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3. RESULTS AND DISCUSSION 
The octapeptide, NHz-Ala-Thr-Asn-Phe-Val- 
Pro-Gly-Lys-COOH, was synthesized as a probe 
for the localization of the carboxyl-terminal region 
Fig.2. Immunogold labelling of LHCII with octapeptide antiserum. Electron micrograph of a spinach leaf section 
embedded in LR gold resin and treated with octapeptide antibodies followed by goat anti-rabbit 10 nm gold. 
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of LHCII [7,1 l-141. The octapeptide was coupled 
to BSA and injected into rabbits. The specificity of 
the antiserum obtained was tested by immunoblots 
of spinach thylakoid proteins separated by SDS- 
PAGE. The octapeptide antiserum cross-reacted 
with only the 28 and 26 kDa Chl a/b-proteins with 
thylakoid membranes or isolated LHCII (fig. l), as 
did polyvalent LHCII antiserum. Further, if the 
antiserum was pretreated with destacked 
thylakoids or LHCII, it no longer cross-reacted 
with LHCII on immunoblots. These results show 
that the octapeptide antiserum is highly specific for 
LHCII. 
Immunogold labelling of chloroplasts in spinach 
leaf sections with the octapeptide antiserum 
showed that about 85% of the gold label occurred 
in the appressed membranes (fig.2). Since this im- 
munogold labelling pattern was identical to that 
observed with polyvalent LHCII antisera [20], it is 
clear that the octapeptide serum is reacting with 
the total pool of LHCII, and not a specific sub- 
population. 
As LHCII is located mainly in the appressed 
membrane region [l] and hence is inaccessible to 
antibodies, it was first necessary for the agglutina- 
tion studies to induce destacking of the thylakoid 
membranes. Suspension of thylakoids in a low-salt 
medium leads to destacking and mixing of all 
thylakoid components including LHCII in the 
membrane plane [21]. Intact, destacked thylakoids 
treated with octapeptide antiserum showed a 
marked, rapid agglutination (fig.3A) that was 
almost as strong as that obtained with polyvalent 
LHCII, whereas they were not agglutinated with 
control preimmune serum (fig.3B). There was no 
agglutination with the pretreated LHCII-absorbed 
octapeptide antiserum (fig.3C) showing that the 
agglutination observed with destacked thylakoids 
was indeed specific for LHCII. Significant ag- 
glutination was observed also with right-side-out 
vesicles of uniform composition but not with 
inside-out vesicles. Hence our results suggest that 
the carboxyl-termini of the main Chl a/b-proteins 
of LHCII are exposed to the chloroplast stroma at 
the outer membrane surface. 
3.1. Model for the transmembrane arrangement 
of the main Chl a/b-proteins of LHCII 
Our experimental finding that the carboxyl- 
terminus of the main LHCII apoprotein is located 
at the outer membrane surface, as is the amino- 
terminus [6], suggests that LHCII must contain an 
Fig.3. Agglutination of spinach thylakoid membranes. (A) Destacked spinach thylakoids mixed with octapeptide 
antiserum at a 1: 5 dilution. (B) Destacked thylakoids plus preimmune serum. (C) Destacked thylakoids plus pretreated 
LHCII-absorbed octapeptide antiserum. x 390. 
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even number of transmembrane domains. Conse- 
quently, these results are inconsistent with the 
three transmembrane domain model of Karlin- 
Neumann et al. [12] based on hydropathy plot 
analysis which has the carboxyl-terminus located 
at the inner, lumenal surface. 
We used a modified algorithm of Chou and 
Fasman [22] to predict the secondary structure of 
the LHCII polypeptide sequence deduced for a 
Lemna Chl a/b-protein [12]. Five putative cy- 
helical regions (residues 59-82, 87- 111, 117- 140, 
161-177 and 183-207) were observed in the Chl 
a/b-protein sequence. Since our data support a 
model with an even number of membrane- 
spanning domains, and four of the putative cy- 
helical regions that each contain 24 or 25 amino 
acid residues are sufficiently long to extend across 
the membrane, our model has four transmembrane 
domains (fig.4). The shorter a-helical region 
(residues 161-171) that contains four negatively 
charged and two positively charged amino acid 
residues is unlikely to be buried within the mem- 
brane core. The proposed four transmembrane do- 
mains contain 43% of the total amino acids and 
with a-helix V, the Chl a/b-protein has an cr- 
helical content of 50%, consistent with the 
ultraviolet circular dichroic results of 44 +: 7% cy- 
helical content [23]. Although the four transmem- 
brane helices contain twelve charged amino acids, 
six can form three salt bridges on the a-helix 
(residues 59-62, a-helix I; 136-139, n-helix III; 
200-204, cr-helix IV); two glutamate residues are 
in a-helix I, and one aspartate, two glutamate and 
one lysine residue are in a-helix II (fig.4). Consis- 
tent with their preferred location in intrinsic pro- 
teins, all four methionine and two of the three 
histidine residues of the Chl a/b-prdtein are in the 
transmembrane domains, while only two of the 
sixteen proline residues are buried in the mem- 
brane. Thus, there is a significant difference be- 
tween the amino acids that are buried in the 
transmembrane domains from those located at the 
membrane surfaces. 
The proposed model (fig.4) is consistent with 
structural analyses of two-dimensional LHCII 
crystals [15,16]. First, some 37% of the amino 
acids of the Chl a/b-protein are exposed at the 
outer membrane surface, but only 20% at the inner 
surface (fig.4). This proposed distribution is con- 
sistent with structural analyses [15,16] which show 
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Fig.4. Model of the polypeptide chain organization of 
the main Chl a/b-protein of LHCII. 
LHCII protruding lo-15 A from one side of the 
membrane, but only 7-10 A on the other. Second, 
Kiihlbrandt [IS] shows LHCII as a trimer, with 
two trimeric units per unit cell (fig.3 of [15]); each 
of the three subunits appears to have four cylin- 
drical domains, 3 prominent outer domains, A-C 
(15-10 a diameter) and a smaller, central bridging 
domain, D (11 A diameter). The lower side con- 
tains two prominent domains that match up with 
domains A and D. We suggest that the bridging 
domains of the two-dimensional LHCII crystals 
[15] represent he interaction of 3 similar cu-helices 
of each LHCII unit acting in series to form a 
parallel, tilted super a-helical coil interacting close- 
ly together at the top (10 A center to center) and 
angled out at the bottom of the crystal (30 A, 
center to center). The tilted transmembrane a- 
helical structure of LHCII with compact globular 
domains at both membrane surfaces and a charged 
a-helix located at the inner membrane surface is 
analogous to that of the photosynthetic bacterial 
reaction center complex [24]. We suggest that the 
28 kDa apoprotein of LHCII has four transmem- 
brane domains with the carboxyl- and amino- 
termini located at the outer membrane surface, but 
further studies are needed to verify this model. 
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